Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel TAP block for pain after hysterectomy
NCT02400645Phase 1Terminated
- Sponsor
- University of Tennessee
- Start
- Mar 2015
- Primary completion
- May 2016
01
Overview
Phase 1, randomised, double-blind trial of bupivacaine extended release liposome injection in postoperative pain, sponsored by University of Tennessee. Primary endpoint: Visual Analog pain scores at 2 hours. Started Mar 2015; status: terminated.
02
Drugs
bupivacaine extended release liposome injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02400645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02400645.